https://myles-innovation.com/tags/innovation-management/Recent content in Innovation Management on MYLES — Strategy & Innovation ConsultingHugoenSun, 15 Mar 2026 00:00:00 +0100https://myles-innovation.com/blog/innovation-culture-enterprise/Sun, 15 Mar 2026 00:00:00 +0100https://myles-innovation.com/blog/innovation-culture-enterprise/<h2 id="the-culture-delusion">The Culture Delusion</h2> <p>&ldquo;We need to change our innovation culture.&rdquo;</p> <p>If I had a euro for every time a VP of Innovation said this to me, I could fund a reasonably sized Series A. It is the default diagnosis for every innovation failure: our products are mediocre because our culture does not support innovation. The prescription follows logically: change the culture.</p> <p>The result is a predictable parade of culture initiatives. Innovation labs. Hackathons. Failure celebrations (&ldquo;fail fast, fail forward!&rdquo;). Inspirational posters featuring Einstein quotes. Innovation ambassadors with colorful lanyards. Maybe a trip to Silicon Valley to absorb the California vibe.</p>https://myles-innovation.com/pillar/systematic-enterprise-innovation/Sun, 15 Mar 2026 00:00:00 +0100https://myles-innovation.com/pillar/systematic-enterprise-innovation/<h2 id="the-problem-with-innovation-in-large-organizations">The Problem With Innovation in Large Organizations</h2> <p>An Austrian manufacturer of precision agricultural equipment invests 8% of annual revenue in R&amp;D. The engineers are among the best in Europe. The patents are real. The product quality is demonstrably superior by any technical measure. And yet the company has been losing market share for four consecutive years to a competitor from Eastern Europe whose products are technically inferior by almost every specification.</p>https://myles-innovation.com/blog/innovation-management-enterprise/Tue, 10 Mar 2026 00:00:00 +0100https://myles-innovation.com/blog/innovation-management-enterprise/<h2 id="the-organizational-immune-system">The Organizational Immune System</h2> <p>Every large enterprise has an immune system. Not biological — organizational. This immune system is programmed to detect deviations from the status quo and neutralize them. It operates through budgeting processes, incentive structures, stage-gate procedures, governance bodies, and cultural norms that accumulated over decades.</p> <p>The immune system is not malicious. It is useful. It protects the enterprise from uncontrolled change, from uncalculated risk, and from the chaos that would ensue if every manager pursued their own agenda simultaneously. Without this immune system, no large organization would function.</p>https://myles-innovation.com/blog/innovation-portfolio-management/Wed, 04 Mar 2026 00:00:00 +0100https://myles-innovation.com/blog/innovation-portfolio-management/<h2 id="the-portfolio-that-manages-you">The Portfolio That Manages You</h2> <p>Most companies that believe they manage an innovation portfolio are actually managed by one. They have existing product lines that generate the revenue used to fund next-generation development. Those existing lines have customers, commitments, and internal advocates who are very good at making the case for incremental improvement. New growth opportunities have hypothetical future value and internal advocates who are newer, less senior, and less skilled at organizational politics.</p>